Press Releases July 16, 2026 04:05 PM

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

iRhythm Holdings schedules Q2 2026 earnings release and conference call for August 6, 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
IRTC

iRhythm Holdings, a digital health care company specializing in wearable biosensors and cloud data analytics for disease detection and prevention, announced it will report its second quarter 2026 financial results after market close on August 6, 2026. A management conference call and webcast will follow to discuss the results.

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
IRTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • iRhythm Holdings will release its Q2 2026 financial results on August 6, 2026 after market close.
  • The company develops wearable biosensors and cloud-based analytics focused on heart disease detection and prevention.
  • A live webcast and conference call will be available to investors and interested parties to discuss the quarter's results.

SAN FRANCISCO, July 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
investors@irhythmtech.com

Media Contact
Kassandra Perry
mediarelations@irhythmtech.com


Risks

  • The earnings report could reflect lower than expected financial or operational performance.
  • Market uncertainty about adoption rates or competitive developments in digital health care wearables.
  • Potential regulatory or reimbursement challenges that impact the company's growth or profitability.

More from Press Releases

Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform Sep 21, 2026 Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal Sep 21, 2026 newcleo Completes Business Combination, Raises $247 Million and Will Start Trading on Nasdaq Under Ticker Symbol “NWCL” on September 22, 2026 Sep 21, 2026 Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference Sep 21, 2026 Host Digital Inc. Announces Closing of Common Stock Offering Sep 21, 2026